Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
about
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionMutation Profile of Well-Differentiated Thyroid Cancer in AsiansNon-synonymous FGD3 Variant as Positional Candidate for Disproportional Tall Stature Accounting for a Carcass Weight QTL (CW-3) and Skeletal Dysplasia in Japanese Black CattlePax-8-PPAR-γ fusion protein in thyroid carcinomaIncreasing the number of thyroid lesions classes in microarray analysis improves the relevance of diagnostic markersIdentification of SERPINA1 as single marker for papillary thyroid carcinoma through microarray meta analysis and quantification of its discriminatory power in independent validation.Telomere length is related to alternative splice patterns of telomerase in thyroid tumors.Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?Pioglitazone induces a proadipogenic antitumor response in mice with PAX8-PPARgamma fusion protein thyroid carcinoma.Activation of peroxisome proliferator-activated receptor gamma contributes to the survival of T lymphoma cells by affecting cellular metabolism.Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.Mouse models of thyroid cancer: A 2015 update.MicroRNA expression profiles in differentiated thyroid cancer, a reviewPoorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.Aquaporins--new players in cancer biology.Genetic alterations in thyroid cancer: the role of mouse models.Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.Do benign thyroid nodules have malignant potential? An evidence-based review.Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma-A Preliminary Study.Molecular pathology of thyroid cancer: diagnostic and clinical implications.Paired box gene 8-peroxisome proliferator-activated receptor-gamma fusion protein and loss of phosphatase and tensin homolog synergistically cause thyroid hyperplasia in transgenic mice.Genetics and epigenetics of sporadic thyroid cancer.Expression of the PAX8/PPARγ Fusion Protein Is Associated with Decreased Neovascularization In Vivo: Impact on Tumorigenesis and Disease Prognosis.Fibrillin expression and localization in various types of carcinomas of the thyroid gland.Serum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseases.The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.p210(BCR-ABL) reprograms transformed and normal human megakaryocytic progenitor cells into erythroid cells and suppresses FLI-1 transcription.Tumor suppressor control of the cancer stem cell niche.[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
P2860
Q24601222-D9329F70-D45C-4F9C-A275-CDF2917A6DE4Q26782322-64D2599A-EDC8-4724-98BC-8854F56E309FQ27310532-ED909A58-6A87-4125-893F-81D04454439BQ28244806-37AF7833-6484-47FD-B410-C2DB708BBF8EQ33515256-DD0748FE-76FA-434B-8DA0-0C154A3A5D0EQ33864242-EEDE0703-9DA4-4807-BB98-889C59154C0DQ35168048-0B55202B-E1B2-476F-B4F6-3BF8508B207FQ35245970-E6C45F8C-330C-4797-98A4-D70E5AB8AAAEQ35417323-8A48B6F6-47EE-4910-9252-B89D697D2E67Q35750111-5EBD22E7-D90C-4D6A-A09F-9FD484BEDA5FQ36297073-BF131DCF-8630-4DC8-AB27-084DF7BDA779Q36405539-B97FFFB3-A0E5-4387-B334-2A792CFE6361Q36449793-146A609B-0D9A-49DB-9B0A-BAFEC4C5F6E3Q36610272-CFC7954C-3F27-45A7-9E85-EB2F4459B563Q36661699-CCB92892-733D-4571-97AB-2A37BD622D9BQ36696228-9F890AC5-F212-4CCC-B578-4DED0A6D51F8Q36887299-97629205-208F-41E2-9C47-F8DDB1EF7C8CQ37104713-A8BA9879-9533-4FCD-9195-AF4F99481217Q37280469-6E2F5171-C2B3-4D99-803E-F82FE533392BQ37337504-EC57C22A-3A3B-403D-9F30-591080181864Q37418218-79A36E1C-F58F-46A0-A95A-27BD8280AB8CQ38128097-2A7DF1D0-3695-472B-B0F3-6963658F1870Q38414822-1430D7F4-A9F8-43DC-820B-0F6429827712Q38438517-A6FE36A9-C448-4152-8B01-F053571BF55DQ38613316-AEE463FA-45B3-42EE-B659-628E916325B6Q39097129-5B663D09-2139-4CFB-87CD-C0EC1184C1CFQ40168316-38B0BE41-F913-4CD0-AB7A-8F23EE86128DQ42486439-50E6423E-4EE7-4A2C-80A2-EA79D74E9FC9Q46985000-7D548A23-9105-44E3-8D7F-E58BBEF077ABQ50935451-B0734613-9ADA-4C79-A3DE-FBD888247231
P2860
Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Follicular thyroid tumors with ...... cteristic genetic alterations.
@en
type
label
Follicular thyroid tumors with ...... cteristic genetic alterations.
@en
prefLabel
Follicular thyroid tumors with ...... cteristic genetic alterations.
@en
P2093
P2860
P1476
Follicular thyroid tumors with ...... cteristic genetic alterations.
@en
P2093
Bernard Caillou
Hugues Ripoche
Jean-Michel Bidart
Jean-Pierre Levillain
Ludovic Lacroix
Martin Schlumberger
Monique Talbot
Philippe Dessen
Vladimir Lazar
P2860
P304
P356
10.1016/S0002-9440(10)62967-7
P407
P577
2005-07-01T00:00:00Z